Figure 5From: Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetesNumbers of patients with intestinal side-effects receiving placebo (n = 55), 100 mg acarbose (n = 54), and 100 mg acarbose with stepwise dosing (n = 55) during 12-week treatment. Adapted with permission from May. [72]Back to article page